JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
ADMA Biologics to Present at the 2015 JMP Securities Life Sciences Conference
-
Horizon Pharma plc Updates Presentation Time at the JMP Securities 2015 Life Sciences Conference
-
Marinus Pharmaceuticals to Present at JMP Securities Life Sciences Conference
-
Antares Pharma to Present at the JMP Securities Life Sciences Conference
-
Akebia to Present at the 2015 JMP Securities Life Sciences Conference
-
ProQR to Present at the JMP Securities Life Science Conference
-
BioLineRx to Present at the JMP Securities Life Sciences Conference in New York
-
ProQR to Present at the JMP Securities Life Science Conference
-
JMP Securities Downgrades Ryland Group (RYL) to Market Perform
-
Ooma, Inc. (OOMA) Files $86.3M Common Stock IPO
-
OraSure Technologies to Present at the 2015 JMP Securities Life Sciences Conference
-
OraSure Technologies to Present at the 2015 JMP Securities Life Sciences Conference
-
Pernix Therapeutics Inc. to Present at JMP Securities Life Sciences Conference
-
Pernix Therapeutics Inc. to Present at JMP Securities Life Sciences Conference
-
Notable Analyst Rating Changes 6/15: (JBL) (PBR) (LOW) Upgraded; (EMC) (MU) (TDC) Downgraded
-
Heron Therapeutics, Inc. Closes Underwritten Offering of Common Stock
-
Intrexon (XON), Harvest Capital Strategies Enter Fund Collaboration
-
Intrexon Forms Multi-Year Collaboration with New Dedicated Fund
-
Epizyme, Inc. to Present at Upcoming Events in June
-
Agile Therapeutics to Present at the JMP Securities Life Sciences Conference 2015
-
Compugen to Present at JMP Securities Life Sciences Conference in New York
-
Summit to Present at JMP Securities Life Sciences Conference
-
JMP Securities Downgrades Teradata (TDC) to Market Underperform
-
Symmetry Surgical to Present at JMP Securities Life Sciences Conference
-
Biotie Therapies (BITI) IPO Opens Up 22%
-
Axovant Sciences (AXON) IPO Opens Up 40%
-
Axovant Sciences (AXON) IPO Prices at Top End of Range
-
TubeMogul (TUBE) Prices 5.26M Common Stock Follow-on at $15.75/Share
-
Axovant Sciences Ltd. Announces Pricing of Initial Public Offering
-
TubeMogul Prices Follow-On Offering
-
TubeMogul Prices Follow-On Offering
-
Nevro to Present at the JMP Securities Life Sciences Conference
-
K2M Group Holdings, Inc. to Present at the JMP Securities Life Sciences Conference 2015
-
K2M Group Holdings, Inc. to Present at the JMP Securities Life Sciences Conference 2015
-
FORUM Pharmaceuticals Inc. Announces Presentations at Upcoming Industry and Investor Conferences
-
Heron Therapeutics (HRTX) Prices 4.8M Common Offering at $24.75/Share
-
Heron Therapeutics, Inc. Announces Pricing of Underwritten Offering of Common Stock
-
JMP Securities Upgrades Hovnanian Enterprises (HOV) to Market Perform
-
Nexvet to Present at the JMP Securities Life Sciences Conference 2015
-
Nexvet to Present at the JMP Securities Life Sciences Conference 2015
-
HTG Molecular Diagnostics to Present at the JMP Securities Life Sciences Conference
-
HTG Molecular Diagnostics to Present at the JMP Securities Life Sciences Conference
-
Adamas Pharmaceuticals to Present at the 2015 JMP Securities Life Science Conference
-
Adamas Pharmaceuticals to Present at the 2015 JMP Securities Life Science Conference
-
JMP Securities Starts Fortress Transportation (FTAI) at Market Outperform
-
Parnell Pharmaceuticals Holdings Ltd to Participate in Two Upcoming Investor Conferences
-
MINDBODY (MB) Sees IPO Price of $13 - $15/Share
-
Trimel to Present at the JMP Securities Life Sciences Conference 2015
-
Blueprint Medicines to Present at Upcoming Investor Conferences in June
-
JMP Securities Upgrades Mindray Medical (MR) to Market Perform

